ARVILAP
ARVILAP
Suspended
- Rabbit haemorrhagic disease virus, strain LO1, Inactivated
Product identification
Medicine name:
ARVILAP
Active substance:
- Rabbit haemorrhagic disease virus, strain LO1, Inactivated
Target species:
-
Rabbit
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabbit haemorrhagic disease virus, strain LO1, Inactivated80.00/haemagglutination inhibiting unit(s)1.00Dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Rabbit
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Suspended
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Ovejero S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Ovejero S.A.U.
Responsible authority:
- Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 2947 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 11/04/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 11/04/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 11/04/2024
How useful was this page?:
